NucMito Pharmaceuticals Co. Ltd.
2 clinical trials · Sponsor
◉ Watch NucMito Pharmaceuticals Co. Ltd.
| Record | Firm | Date |
|---|---|---|
| Safety and Pharmacokinetics of NM6603 in Chinese Patients With Advanced Solid Tumors (NCT07292038) | NucMito Pharmaceuticals Co. Ltd. | 2025-12-18 |
| A Phase 1 Study of NM6603 in Advanced Solid Tumors (NCT06046066) | NucMito Pharmaceuticals Co. Ltd. | 2023-08-31 |
Track NucMito Pharmaceuticals Co. Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.